ESWL Versus SOPIL for Treatment of Pancreatic Duct Stones
Key facts
- Who runs it
- Indiana University
- Where
- Indianapolis, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 13 Nov 2019
- Ended
- 5 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- ESWL vs SOPIL
- Record updated
- 15 September 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (19)Hide the full registry criteria
Who can take part
- MPDS located in the head, neck, or neck/body junction of the pancreas
- MPDS > 5 mm in size
- Abdominal CT scan, Endoscopic ultrasound, or prior ERCP demonstrating MPDS
- Abdominal pain related to MPDS
- Previously failed ERCP performed with intent to clear MPDS, OR MPDS determined by treating physicians to not be amenable to clearance by standard ERCP techniques
Who cannot take part
- Known pancreatic head stricture precluding passage of the pancreatoscope with endoscopic stone extraction based on prior imaging or prior ERCP
- Prior attempts at ESWL or SOPIL for MPDS
- Implanted cardiac pacemakers or defibrillators
- Age < 18 years, pregnancy, incarceration, unwillingness/inability to provide informed consent, or anticipated inability to follow protocol
- MPDS predominantly located in the body and tail of pancreas
- Any obstructing MPDS > 5 mm located in the body and tail of pancreas
- Pancreatic head mass
- Impacted MPDS located at the pancreatic duct orifice
- Walled off pancreatic necrosis
- Active alcohol use, defined as any alcohol use within 2 months
- Surgically altered anatomy (see text)
- Gastric outlet obstruction or obstruction precluding passage of the endoscope
- Standard contraindications to ERCP
- Known calcified aneurysms in the path of the shockwave
Where in United States
- Indiana University Health HospitalIndianapolis, United States
About the trial
What the trial wants to find out
Pancreatic duct stones can cause obstruction of the main pancreatic duct leading to abdominal pain, exocrine pancreatic insufficiency, and recurrent acute pancreatitis. By removing pancreatic duct stones, the obstruction can be relieved, and this can improve symptoms. Small stones can be removed with standard endoscopic retrograde cholangiopancreatography (ERCP) and stone removal, but larger stones may require lithotripsy to break up the stone before removal. The two current methods of lithotripsy include extracorporeal shock wave lithotripsy (ESWL) and single operator pancreatoscopy with intracorporeal lithotripsy (SOPIL).
Read full original descriptionShow less
ESWL is based on concentrating shock wave energy to the stone through an external device. SOPIL is a newer technique based on direct visualization of the stone during ERCP and targeting the stone with a shock wave catheter. There are currently no studies directly comparing ESWL to SOPIL for breaking apart stones in the pancreatic duct, so this study is designed to compare the two techniques.
Objective #1: Obtain pilot data to determine the optimal method of clearing large MPDS Objective #2: Obtain pilot data to assess how effective large MPDS clearance is in improving long term patient centered outcomes Objective #3: Obtain pilot data to measure the cost effectiveness of large MPDS clearance
The 2 groups in the trial
- ESWLExisting treatment, for comparison
Extracorporeal shock wave lithotripsy for the treatment of pancreatic duct stones
Treatment: ESWL vs SOPIL
- SOPILExisting treatment, for comparison
Single Operator Pancreatoscopy and intraductal lithotripsy for the treatment of pancreatic duct stones
Treatment: ESWL vs SOPIL
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Extracorporeal Shock Wave Lithotripsy Versus Single Operator Pancreatoscopy and Intraductal Lithotripsy for the Treatment of Pancreatic Duct Stones
- Record updated
- 15 September 2025